Buspirone Market Trends 2034: Advancements in Pharmaceutical Formulations and Anxiety Treatment
According to The Insight Partners, the Buspirone Market is forecasted to increase from US$ 11.96 billion in 2025 to US$ 24.27 billion by 2034, representing a CAGR of 8.18% from 2026 to 2034. The market is indicative of ongoing demand for non-benzodiazepine anxiolytic treatment due to the medication’s clinical experience, dose adjustment capabilities, and generic offerings. The market's...
0 Kommentare 0 Geteilt 64 Ansichten 0 Bewertungen